Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
Kent Kanao
, Takayuki Takahashi
, Yuta Umezawa
, Takashi Okabe
, Go Kaneko
, Suguru Shirotake
, Koshiro Nishimoto
, Masafumi Oyama
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone'. Together they form a unique fingerprint.